Global Oncology Companion Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 118
Published Date: 02 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Oncology Companion Diagnostic market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Oncology Companion Diagnostic industry chain, the market status of Hospital (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), Pathology/Diagnostic Laboratory (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncology Companion Diagnostic.
Regionally, the report analyzes the Oncology Companion Diagnostic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncology Companion Diagnostic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncology Companion Diagnostic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncology Companion Diagnostic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncology Companion Diagnostic market.
Regional Analysis: The report involves examining the Oncology Companion Diagnostic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncology Companion Diagnostic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncology Companion Diagnostic:
Company Analysis: Report covers individual Oncology Companion Diagnostic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncology Companion Diagnostic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pathology/Diagnostic Laboratory).
Technology Analysis: Report covers specific technologies relevant to Oncology Companion Diagnostic. It assesses the current state, advancements, and potential future developments in Oncology Companion Diagnostic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncology Companion Diagnostic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncology Companion Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
Market segment by Application
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Market segment by players, this report covers
Agilent Technologies, Inc.
Illumina, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Companion Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Companion Diagnostic, with revenue, gross margin and global market share of Oncology Companion Diagnostic from 2019 to 2024.
Chapter 3, the Oncology Companion Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncology Companion Diagnostic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Companion Diagnostic.
Chapter 13, to describe Oncology Companion Diagnostic research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oncology Companion Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Companion Diagnostic by Type
1.3.1 Overview: Global Oncology Companion Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncology Companion Diagnostic Consumption Value Market Share by Type in 2023
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Next-Generation Sequencing (NGS)
1.3.5 Immunohistochemistry (IHC)
1.3.6 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
1.3.7 Others
1.4 Global Oncology Companion Diagnostic Market by Application
1.4.1 Overview: Global Oncology Companion Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pathology/Diagnostic Laboratory
1.4.4 Academic Medical Center
1.5 Global Oncology Companion Diagnostic Market Size & Forecast
1.6 Global Oncology Companion Diagnostic Market Size and Forecast by Region
1.6.1 Global Oncology Companion Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncology Companion Diagnostic Market Size by Region, (2019-2030)
1.6.3 North America Oncology Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.4 Europe Oncology Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncology Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.6 South America Oncology Companion Diagnostic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncology Companion Diagnostic Market Size and Prospect (2019-2030)
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Product and Solutions
2.1.4 Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Illumina, Inc.
2.2.1 Illumina, Inc. Details
2.2.2 Illumina, Inc. Major Business
2.2.3 Illumina, Inc. Oncology Companion Diagnostic Product and Solutions
2.2.4 Illumina, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Illumina, Inc. Recent Developments and Future Plans
2.3 Qiagen N.V.
2.3.1 Qiagen N.V. Details
2.3.2 Qiagen N.V. Major Business
2.3.3 Qiagen N.V. Oncology Companion Diagnostic Product and Solutions
2.3.4 Qiagen N.V. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Qiagen N.V. Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
2.4.1 Thermo Fisher Scientific Inc. Details
2.4.2 Thermo Fisher Scientific Inc. Major Business
2.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product and Solutions
2.4.4 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 ARUP Laboratories
2.6.1 ARUP Laboratories Details
2.6.2 ARUP Laboratories Major Business
2.6.3 ARUP Laboratories Oncology Companion Diagnostic Product and Solutions
2.6.4 ARUP Laboratories Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ARUP Laboratories Recent Developments and Future Plans
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Oncology Companion Diagnostic Product and Solutions
2.7.4 Abbott Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbott Recent Developments and Future Plans
2.8 Myriad Genetics, Inc.
2.8.1 Myriad Genetics, Inc. Details
2.8.2 Myriad Genetics, Inc. Major Business
2.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Product and Solutions
2.8.4 Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.9 bioMérieux SA
2.9.1 bioMérieux SA Details
2.9.2 bioMérieux SA Major Business
2.9.3 bioMérieux SA Oncology Companion Diagnostic Product and Solutions
2.9.4 bioMérieux SA Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 bioMérieux SA Recent Developments and Future Plans
2.10 Invivoscribe, Inc.
2.10.1 Invivoscribe, Inc. Details
2.10.2 Invivoscribe, Inc. Major Business
2.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Product and Solutions
2.10.4 Invivoscribe, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Invivoscribe, Inc. Recent Developments and Future Plans
3.1 Global Oncology Companion Diagnostic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Oncology Companion Diagnostic by Company Revenue
3.2.2 Top 3 Oncology Companion Diagnostic Players Market Share in 2023
3.2.3 Top 6 Oncology Companion Diagnostic Players Market Share in 2023
3.3 Oncology Companion Diagnostic Market: Overall Company Footprint Analysis
3.3.1 Oncology Companion Diagnostic Market: Region Footprint
3.3.2 Oncology Companion Diagnostic Market: Company Product Type Footprint
3.3.3 Oncology Companion Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Oncology Companion Diagnostic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Oncology Companion Diagnostic Market Forecast by Type (2025-2030)
5.1 Global Oncology Companion Diagnostic Consumption Value Market Share by Application (2019-2024)
5.2 Global Oncology Companion Diagnostic Market Forecast by Application (2025-2030)
6.1 North America Oncology Companion Diagnostic Consumption Value by Type (2019-2030)
6.2 North America Oncology Companion Diagnostic Consumption Value by Application (2019-2030)
6.3 North America Oncology Companion Diagnostic Market Size by Country
6.3.1 North America Oncology Companion Diagnostic Consumption Value by Country (2019-2030)
6.3.2 United States Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
6.3.3 Canada Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
6.3.4 Mexico Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
7.1 Europe Oncology Companion Diagnostic Consumption Value by Type (2019-2030)
7.2 Europe Oncology Companion Diagnostic Consumption Value by Application (2019-2030)
7.3 Europe Oncology Companion Diagnostic Market Size by Country
7.3.1 Europe Oncology Companion Diagnostic Consumption Value by Country (2019-2030)
7.3.2 Germany Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.3 France Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.5 Russia Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
7.3.6 Italy Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Oncology Companion Diagnostic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncology Companion Diagnostic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncology Companion Diagnostic Market Size by Region
8.3.1 Asia-Pacific Oncology Companion Diagnostic Consumption Value by Region (2019-2030)
8.3.2 China Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.3 Japan Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.4 South Korea Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.5 India Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
8.3.7 Australia Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
9.1 South America Oncology Companion Diagnostic Consumption Value by Type (2019-2030)
9.2 South America Oncology Companion Diagnostic Consumption Value by Application (2019-2030)
9.3 South America Oncology Companion Diagnostic Market Size by Country
9.3.1 South America Oncology Companion Diagnostic Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
9.3.3 Argentina Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Oncology Companion Diagnostic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncology Companion Diagnostic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Country
10.3.1 Middle East & Africa Oncology Companion Diagnostic Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
10.3.4 UAE Oncology Companion Diagnostic Market Size and Forecast (2019-2030)
11.1 Oncology Companion Diagnostic Market Drivers
11.2 Oncology Companion Diagnostic Market Restraints
11.3 Oncology Companion Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Oncology Companion Diagnostic Industry Chain
12.2 Oncology Companion Diagnostic Upstream Analysis
12.3 Oncology Companion Diagnostic Midstream Analysis
12.4 Oncology Companion Diagnostic Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oncology Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oncology Companion Diagnostic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Oncology Companion Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Oncology Companion Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies, Inc. Major Business
Table 7. Agilent Technologies, Inc. Oncology Companion Diagnostic Product and Solutions
Table 8. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 10. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 11. Illumina, Inc. Major Business
Table 12. Illumina, Inc. Oncology Companion Diagnostic Product and Solutions
Table 13. Illumina, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Illumina, Inc. Recent Developments and Future Plans
Table 15. Qiagen N.V. Company Information, Head Office, and Major Competitors
Table 16. Qiagen N.V. Major Business
Table 17. Qiagen N.V. Oncology Companion Diagnostic Product and Solutions
Table 18. Qiagen N.V. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Qiagen N.V. Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Inc. Major Business
Table 22. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product and Solutions
Table 23. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 25. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 26. F. Hoffmann-La Roche Ltd. Major Business
Table 27. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product and Solutions
Table 28. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 30. ARUP Laboratories Company Information, Head Office, and Major Competitors
Table 31. ARUP Laboratories Major Business
Table 32. ARUP Laboratories Oncology Companion Diagnostic Product and Solutions
Table 33. ARUP Laboratories Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. ARUP Laboratories Recent Developments and Future Plans
Table 35. Abbott Company Information, Head Office, and Major Competitors
Table 36. Abbott Major Business
Table 37. Abbott Oncology Companion Diagnostic Product and Solutions
Table 38. Abbott Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Abbott Recent Developments and Future Plans
Table 40. Myriad Genetics, Inc. Company Information, Head Office, and Major Competitors
Table 41. Myriad Genetics, Inc. Major Business
Table 42. Myriad Genetics, Inc. Oncology Companion Diagnostic Product and Solutions
Table 43. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Myriad Genetics, Inc. Recent Developments and Future Plans
Table 45. bioMérieux SA Company Information, Head Office, and Major Competitors
Table 46. bioMérieux SA Major Business
Table 47. bioMérieux SA Oncology Companion Diagnostic Product and Solutions
Table 48. bioMérieux SA Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. bioMérieux SA Recent Developments and Future Plans
Table 50. Invivoscribe, Inc. Company Information, Head Office, and Major Competitors
Table 51. Invivoscribe, Inc. Major Business
Table 52. Invivoscribe, Inc. Oncology Companion Diagnostic Product and Solutions
Table 53. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Invivoscribe, Inc. Recent Developments and Future Plans
Table 55. Global Oncology Companion Diagnostic Revenue (USD Million) by Players (2019-2024)
Table 56. Global Oncology Companion Diagnostic Revenue Share by Players (2019-2024)
Table 57. Breakdown of Oncology Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Oncology Companion Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Oncology Companion Diagnostic Players
Table 60. Oncology Companion Diagnostic Market: Company Product Type Footprint
Table 61. Oncology Companion Diagnostic Market: Company Product Application Footprint
Table 62. Oncology Companion Diagnostic New Market Entrants and Barriers to Market Entry
Table 63. Oncology Companion Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Oncology Companion Diagnostic Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Oncology Companion Diagnostic Consumption Value Share by Type (2019-2024)
Table 66. Global Oncology Companion Diagnostic Consumption Value Forecast by Type (2025-2030)
Table 67. Global Oncology Companion Diagnostic Consumption Value by Application (2019-2024)
Table 68. Global Oncology Companion Diagnostic Consumption Value Forecast by Application (2025-2030)
Table 69. North America Oncology Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Oncology Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Oncology Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Oncology Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Oncology Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Oncology Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Oncology Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Oncology Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Oncology Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Oncology Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Oncology Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Oncology Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Oncology Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Oncology Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Oncology Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Oncology Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Oncology Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Oncology Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Oncology Companion Diagnostic Raw Material
Table 100. Key Suppliers of Oncology Companion Diagnostic Raw Materials
List of Figures
Figure 1. Oncology Companion Diagnostic Picture
Figure 2. Global Oncology Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oncology Companion Diagnostic Consumption Value Market Share by Type in 2023
Figure 4. Polymerase Chain Reaction (PCR)
Figure 5. Next-Generation Sequencing (NGS)
Figure 6. Immunohistochemistry (IHC)
Figure 7. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Figure 8. Others
Figure 9. Global Oncology Companion Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Oncology Companion Diagnostic Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Pathology/Diagnostic Laboratory Picture
Figure 13. Academic Medical Center Picture
Figure 14. Global Oncology Companion Diagnostic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Oncology Companion Diagnostic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Oncology Companion Diagnostic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Oncology Companion Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Oncology Companion Diagnostic Consumption Value Market Share by Region in 2023
Figure 19. North America Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Oncology Companion Diagnostic Revenue Share by Players in 2023
Figure 25. Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Oncology Companion Diagnostic Market Share in 2023
Figure 27. Global Top 6 Players Oncology Companion Diagnostic Market Share in 2023
Figure 28. Global Oncology Companion Diagnostic Consumption Value Share by Type (2019-2024)
Figure 29. Global Oncology Companion Diagnostic Market Share Forecast by Type (2025-2030)
Figure 30. Global Oncology Companion Diagnostic Consumption Value Share by Application (2019-2024)
Figure 31. Global Oncology Companion Diagnostic Market Share Forecast by Application (2025-2030)
Figure 32. North America Oncology Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Oncology Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Oncology Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Oncology Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Oncology Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Oncology Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 42. France Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Oncology Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Oncology Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Oncology Companion Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 49. China Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 52. India Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Oncology Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Oncology Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Oncology Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Oncology Companion Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Oncology Companion Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Oncology Companion Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Oncology Companion Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 66. Oncology Companion Diagnostic Market Drivers
Figure 67. Oncology Companion Diagnostic Market Restraints
Figure 68. Oncology Companion Diagnostic Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Oncology Companion Diagnostic in 2023
Figure 71. Manufacturing Process Analysis of Oncology Companion Diagnostic
Figure 72. Oncology Companion Diagnostic Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Agilent Technologies, Inc. Illumina, Inc. Qiagen N.V. Thermo Fisher Scientific Inc. F. Hoffmann-La Roche Ltd. ARUP Laboratories Abbott Myriad Genetics, Inc. bioMérieux SA Invivoscribe, Inc.
Related Reports
29 Jan 2021
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
